2024 Overview of Insulin Glargine Biosimilars
Insulin glargine, a long-acting insulin analog, is vital in managing diabetes, offering steady glucose control for up to 24 hours. As diabetes rates continue to rise globally, insulin glargine biosimilars present a more affordable alternative to branded options like Sanofi’s Lantus, easing the financial burden on patie